Skip to content
Screener

Maravai LifeSciences Holdings, Inc. MRVI Corporate — Other Restructuring Costs

Other segment segments

Cygnus
$0-100%
TriLink
$0-100%

Similar metrics at other companies

Campbell Soup logo
CPBCorporate — Other Restructuring Costs
$60M+140%
Fortune Brands Innovations logo
FBINCorporate — Other Restructuring Costs
$2.5M-41.9%
Drilling Tools International logo
DTIOther Restructuring Costs
$48K-92.4%
Airship AI Holdings, Inc. logo
AISPOther Restructuring Costs
$11.28K+43.1%
Campbell Soup logo
CPBSnacks — Other Restructuring Costs
$25M+400%
Eastman Chemical logo
EMNFibers — Other Restructuring Costs
$500K

Other financials

Income statement

See full
Revenue$51.4M+8.5%
Gross profit$20.7M+166%
Operating income-$15.1M+77.2%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
Enterprise value$1.03B+158%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherRestructuringCosts.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026. Open the filing →

Filed
Aug 7, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001823239-26-000059

FAQ

What is Maravai LifeSciences Holdings, Inc.'s corporate — other restructuring costs?
Maravai LifeSciences Holdings, Inc. (MRVI) reported corporate — other restructuring costs of $158K in Q2 2026.
What does corporate — other restructuring costs mean?
Includes miscellaneous expenses directly attributable to corporate-level restructuring activities that do not fall under standard severance or facility exit categories. This metric captures the complexity and breadth of organizational transformation efforts. Investors use this to evaluate the total cost burden of strategic pivots and operational streamlining.

Ask your AI about Maravai LifeSciences Holdings, Inc.'s corporate — other restructuring costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude